Brandes Investment Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$256M Buy
9,107,225
+478,043
+6% +$12.7M 1.81% 11
2025
Q4
$215M Buy
8,629,182
+216,411
+3% +$5.46M 1.64% 15
2025
Q3
$214M Buy
8,412,771
+370,062
+5% +$9.13M 1.72% 15
2025
Q2
$195M Buy
8,042,709
+992,637
+14% +$23.1M 1.76% 15
2025
Q1
$179M Buy
7,050,072
+341,908
+5% +$8.95M 1.82% 15
2024
Q4
$178M Buy
6,708,164
+962,837
+17% +$26.1M 1.99% 10
2024
Q3
$166M Buy
5,745,327
+172,045
+3% +$5.02M 1.87% 15
2024
Q2
$156M Buy
5,573,282
+516,714
+10% +$14.2M 1.92% 14
2024
Q1
$140M Buy
5,056,568
+721,719
+17% +$20M 1.81% 15
2023
Q4
$125M Buy
4,334,849
+1,377,426
+47% +$41.6M 1.89% 13
2023
Q3
$98.1M Buy
2,957,423
+119,009
+4% +$4.21M 1.92% 17
2023
Q2
$104M Buy
2,838,414
+426,855
+18% +$16.6M 2.1% 14
2023
Q1
$98.4M Buy
2,411,559
+431,989
+22% +$18.7M 2.09% 14
2022
Q4
$101M Sell
1,979,570
-321,654
-14% -$15.4M 2.84% 7
2022
Q3
$101M Buy
2,301,224
+29,829
+1% +$1.45M 2.63% 6
2022
Q2
$119M Buy
2,271,395
+1,191
+0.1% +$60.7K 2.91% 6
2022
Q1
$118M Buy
2,270,204
+98,982
+5% +$5.14M 2.52% 8
2021
Q4
$128M Sell
2,171,222
-232,982
-10% -$11.5M 2.8% 4
2021
Q3
$103M Buy
2,404,204
+60,616
+3% +$2.69M 2.24% 8
2021
Q2
$91.8M Buy
2,343,588
+480,678
+26% +$18.7M 2.04% 8
2021
Q1
$67.3M Buy
1,862,910
+73,613
+4% +$2.61M 1.59% 16
2020
Q4
$65.7M Sell
1,789,297
-113,286
-6% -$4.16M 1.69% 13
2020
Q3
$66.2M Sell
1,902,583
-241,252
-11% -$8.46M 2.29% 8
2020
Q2
$66.5M Sell
2,143,835
-268,205
-11% -$9.11M 2.02% 12
2020
Q1
$74.7M Sell
2,412,040
-31,315
-1% -$1.07M 2.61% 6
2019
Q4
$90.8M Sell
2,443,355
-76,824
-3% -$2.74M 2.16% 10
2019
Q3
$85.9M Sell
2,520,179
-122,146
-5% -$4.44M 2.22% 10
2019
Q2
$109M Sell
2,642,325
-146,242
-5% -$5.81M 2.42% 8
2019
Q1
$112M Sell
2,788,567
-418,356
-13% -$16.8M 2.61% 7
2018
Q4
$133M Sell
3,206,923
-313,440
-9% -$13M 3.38% 3
2018
Q3
$147M Sell
3,520,363
-87,544
-2% -$3.37M 3.32% 4
2018
Q2
$124M Sell
3,607,907
-82,831
-2% -$2.83M 2.8% 4
2018
Q1
$124M Sell
3,690,738
-216,734
-6% -$7.45M 2.65% 5
2017
Q4
$134M Sell
3,907,472
-120,565
-3% -$4.11M 2.71% 4
2017
Q3
$136M Sell
4,028,037
-1,383,947
-26% -$44.5M 2.77% 4
2017
Q2
$172M Sell
5,411,984
-930,993
-15% -$29.4M 2.73% 5
2017
Q1
$206M Buy
6,342,977
+786,902
+14% +$24.8M 3.06% 4
2016
Q4
$171M Buy
5,556,075
+252,340
+5% +$7.7M 2.57% 9
2016
Q3
$170M Sell
5,303,735
-209,840
-4% -$7.02M 2.56% 9
2016
Q2
$184M Sell
5,513,575
-321,712
-6% -$10.3M 2.81% 5
2016
Q1
$164M Sell
5,835,287
-108,785
-2% -$3.11M 2.35% 9
2015
Q4
$182M Sell
5,944,072
-236,269
-4% -$7.43M 2.66% 7
2015
Q3
$184M Sell
6,180,341
-201,506
-3% -$6.46M 2.69% 7
2015
Q2
$203M Sell
6,381,847
-72,360
-1% -$2.36M 2.6% 5
2015
Q1
$213M Sell
6,454,207
-156,583
-2% -$4.98M 2.93% 5
2014
Q4
$195M Buy
6,610,790
+15,817
+0.2% +$454K 2.76% 6
2014
Q3
$185M Buy
6,594,973
+191,438
+3% +$5.37M 2.45% 10
2014
Q2
$180M Buy
6,403,535
+349,664
+6% +$9.97M 2.18% 15
2014
Q1
$184M Sell
6,053,871
-24,971
-0.4% -$745K 2.33% 12
2013
Q4
$177M Sell
6,078,842
-625,027
-9% -$18.2M 2.18% 15
2013
Q3
$183M Sell
6,703,869
-117,478
-2% -$3.2M 2.35% 12
2013
Q2
$181M Buy
+6,821,347
New +$188M 2.27% 13

Other funds holding PFE

Brandes Investment Partners's PFE Position: Q1 2026 in Review

Brandes Investment Partners increased its Pfizer (PFE) stake by 5.5% in Q1 2026, buying an estimated $12.7M and bringing the position to 9,107,225 shares worth $256M. The position accounts for 1.81% of the portfolio, ranked #11.

Brandes Investment Partners first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Brandes Investment Partners held 9,107,225 shares of Pfizer worth $256M as of Q1 2026.
  • Brandes Investment Partners bought 478,043 Pfizer shares in Q1 2026, an estimated $12.7M.
  • Pfizer made up 1.81% of Brandes Investment Partners's portfolio in Q1 2026, its #11 holding.
  • Brandes Investment Partners first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Brandes Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.